BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lyons MA, Wittenburg H. Cholesterol gallstone susceptibility loci: a mouse map, candidate gene evaluation, and guide to human LITH genes. Gastroenterology 2006;131:1943-70. [PMID: 17087948 DOI: 10.1053/j.gastro.2006.10.024] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Di Ciaula A, Wang DQ, Portincasa P. Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention. Expert Rev Gastroenterol Hepatol 2019;13:157-71. [PMID: 30791781 DOI: 10.1080/17474124.2019.1549988] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Tönjes A, Wittenburg H, Halbritter J, Renner O, Harsch S, Stange EF, Lammert F, Stumvoll M, Kovacs P. Effects of SLC10A2 variant rs9514089 on gallstone risk and serum cholesterol levels- meta-analysis of three independent cohorts. BMC Med Genet 2011;12:149. [PMID: 22093174 DOI: 10.1186/1471-2350-12-149] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
3 de Bari O, Wang HH, Portincasa P, Paik CN, Liu M, Wang DQ. Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice. Eur J Clin Invest 2014;44:1159-68. [PMID: 25303682 DOI: 10.1111/eci.12350] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
4 Cui Y, Li Z, Zhao E, Cui N. Risk factors in patients with hereditary gallstones in Chinese pedigrees. Med Princ Pract. 2012;21:467-471. [PMID: 22473058 DOI: 10.1159/000337437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
5 Di Ciaula A, Wang DQ, Portincasa P. An update on the pathogenesis of cholesterol gallstone disease. Curr Opin Gastroenterol 2018;34:71-80. [PMID: 29283909 DOI: 10.1097/MOG.0000000000000423] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 12.3] [Reference Citation Analysis]
6 Wang HH, Li T, Portincasa P, Ford DA, Neuschwander-Tetri BA, Tso P, Wang DQ. New insights into the role of Lith genes in the formation of cholesterol-supersaturated bile. Liver Res 2017;1:42-53. [PMID: 34367715 DOI: 10.1016/j.livres.2017.05.005] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
7 Joshi AD, Andersson C, Buch S, Stender S, Noordam R, Weng LC, Weeke PE, Auer PL, Boehm B, Chen C, Choi H, Curhan G, Denny JC, De Vivo I, Eicher JD, Ellinghaus D, Folsom AR, Fuchs C, Gala M, Haessler J, Hofman A, Hu F, Hunter DJ, Janssen HL, Kang JH, Kooperberg C, Kraft P, Kratzer W, Lieb W, Lutsey PL, Darwish Murad S, Nordestgaard BG, Pasquale LR, Reiner AP, Ridker PM, Rimm E, Rose LM, Shaffer CM, Schafmayer C, Tamimi RM, Uitterlinden AG, Völker U, Völzke H, Wakabayashi Y, Wiggs JL, Zhu J, Roden DM, Stricker BH, Tang W, Teumer A, Hampe J, Tybjærg-Hansen A, Chasman DI, Chan AT, Johnson AD. Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies. Gastroenterology 2016;151:351-363.e28. [PMID: 27094239 DOI: 10.1053/j.gastro.2016.04.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 7.7] [Reference Citation Analysis]
8 He J, Nishida S, Xu M, Makishima M, Xie W. PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts. Gastroenterology 2011;140:2095-106. [PMID: 21354151 DOI: 10.1053/j.gastro.2011.02.055] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
9 Xie Y, Newberry EP, Kennedy SM, Luo J, Davidson NO. Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice. J Lipid Res 2009;50:977-87. [PMID: 19136665 DOI: 10.1194/jlr.M800645-JLR200] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
10 Kovacs P, Kress R, Rocha J, Kurtz U, Miquel JF, Nervi F, Méndez-Sánchez N, Uribe M, Bock HH, Schirin-Sokhan R. Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans. J Hepatol. 2008;48:116-124. [PMID: 17931734 DOI: 10.1016/j.jhep.2007.07.027] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 4.1] [Reference Citation Analysis]
11 Lammert F, Miquel JF. Gallstone disease: from genes to evidence-based therapy. J Hepatol. 2008;48 Suppl 1:S124-S135. [PMID: 18308417 DOI: 10.1016/j.jhep.2008.01.012] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
12 Wang HH, Lammert F, Schmitz A, Wang DQ. Transgenic overexpression of Abcb11 enhances biliary bile salt outputs, but does not affect cholesterol cholelithogenesis in mice. Eur J Clin Invest 2010;40:541-51. [PMID: 20456485 DOI: 10.1111/j.1365-2362.2010.02300.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
13 Mehta D, Mehta KD. PKCβ: Expanding role in hepatic adaptation of cholesterol homeostasis to dietary fat/cholesterol. Am J Physiol Gastrointest Liver Physiol 2017;312:G266-73. [PMID: 28104587 DOI: 10.1152/ajpgi.00373.2016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
14 Wang HH, de Bari O, Arnatt CK, Liu M, Portincasa P, Wang DQ. Activation of Estrogen Receptor G Protein-Coupled Receptor 30 Enhances Cholesterol Cholelithogenesis in Female Mice. Hepatology 2020;72:2077-89. [PMID: 32112420 DOI: 10.1002/hep.31212] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
15 Hofmann AF. Biliary secretion and excretion in health and disease: Current concepts. Annals of Hepatology 2007;6:15-27. [DOI: 10.1016/s1665-2681(19)31949-0] [Cited by in Crossref: 94] [Article Influence: 6.3] [Reference Citation Analysis]
16 Huang W, Bansode RR, Xie Y, Rowland L, Mehta M, Davidson NO, Mehta KD. Disruption of the murine protein kinase Cbeta gene promotes gallstone formation and alters biliary lipid and hepatic cholesterol metabolism. J Biol Chem. 2011;286:22795-22805. [PMID: 21550971 DOI: 10.1074/jbc.m111.250282] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
17 Höblinger A, Lammert F. Genetics of biliary tract diseases: new insights into gallstone disease and biliary tract cancers: . Current Opinion in Gastroenterology 2008;24:363-71. [DOI: 10.1097/mog.0b013e3282f79b32] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
18 Johnson LE, Elias MS, Bolick DT, Skaflen MD, Green RM, Hedrick CC. The G protein-coupled receptor G2A: involvement in hepatic lipid metabolism and gallstone formation in mice. Hepatology 2008;48:1138-48. [PMID: 18821587 DOI: 10.1002/hep.22433] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
19 Zanlungo S, Rigotti A, Miquel JF, Nervi F. Abnormalities of lipid metabolism, gallstone disease and gallbladder function. Clinical Lipidology 2011;6:315-25. [DOI: 10.2217/clp.11.22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 DeLeon C, Wang DQ, Arnatt CK. G Protein-Coupled Estrogen Receptor, GPER1, Offers a Novel Target for the Treatment of Digestive Diseases. Front Endocrinol (Lausanne) 2020;11:578536. [PMID: 33281743 DOI: 10.3389/fendo.2020.578536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Marschall HU, Katsika D, Rudling M, Einarsson C. The genetic background of gallstone formation: an update. Biochem Biophys Res Commun. 2010;396:58-62. [PMID: 20494111 DOI: 10.1016/j.bbrc.2010.02.143] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
22 Sabeva NS, Rouse EJ, Graf GA. Defects in the Leptin Axis Reduce Abundance of the ABCG5-ABCG8 Sterol Transporter in Liver. Journal of Biological Chemistry 2007;282:22397-405. [DOI: 10.1074/jbc.m702236200] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
23 Wang HH, Portincasa P, Liu M, Tso P, Wang DQ. An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13. Genes (Basel) 2020;11:E1438. [PMID: 33260332 DOI: 10.3390/genes11121438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 de Bari O, Wang TY, Liu M, Portincasa P, Wang DQ. Estrogen induces two distinct cholesterol crystallization pathways by activating ERα and GPR30 in female mice. J Lipid Res 2015;56:1691-700. [PMID: 26152119 DOI: 10.1194/jlr.M059121] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
25 Stokes CS, Lammert F. Transporters in cholelithiasis. Biological Chemistry 2012;393:3-10. [DOI: 10.1515/bc-2011-226] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
26 Wang HH, Portincasa P, Liu M, Wang DQ. Genetic Analysis of ABCB4 Mutations and Variants Related to the Pathogenesis and Pathophysiology of Low Phospholipid-Associated Cholelithiasis. Genes (Basel) 2022;13:1047. [PMID: 35741809 DOI: 10.3390/genes13061047] [Reference Citation Analysis]
27 Krawczyk M, Müllenbach R, Weber SN, Zimmer V, Lammert F. Genome-wide association studies and genetic risk assessment of liver diseases. Nat Rev Gastroenterol Hepatol. 2010;7:669-681. [PMID: 21045792 DOI: 10.1038/nrgastro.2010.170] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
28 de Bari O, Wang HH, Portincasa P, Liu M, Wang DQ. The deletion of the estrogen receptor α gene reduces susceptibility to estrogen-induced cholesterol cholelithiasis in female mice. Biochim Biophys Acta 2015;1852:2161-9. [PMID: 26232687 DOI: 10.1016/j.bbadis.2015.07.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
29 Grünhage F, Acalovschi M, Tirziu S, Walier M, Wienker TF, Ciocan A, Mosteanu O, Sauerbruch T, Lammert F. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol. Hepatology 2007;46:793-801. [PMID: 17626266 DOI: 10.1002/hep.21847] [Cited by in Crossref: 119] [Cited by in F6Publishing: 101] [Article Influence: 7.9] [Reference Citation Analysis]
30 Wang TY, Portincasa P, Liu M, Tso P, Wang DQ. Mouse models of gallstone disease. Curr Opin Gastroenterol 2018;34:59-70. [PMID: 29266008 DOI: 10.1097/MOG.0000000000000417] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
31 Zwicker BL, Agellon LB. Transport and biological activities of bile acids. Int J Biochem Cell Biol 2013;45:1389-98. [PMID: 23603607 DOI: 10.1016/j.biocel.2013.04.012] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 6.6] [Reference Citation Analysis]
32 Atshaves BP, Martin GG, Hostetler HA, McIntosh AL, Kier AB, Schroeder F. Liver fatty acid-binding protein and obesity. J Nutr Biochem 2010;21:1015-32. [PMID: 20537520 DOI: 10.1016/j.jnutbio.2010.01.005] [Cited by in Crossref: 129] [Cited by in F6Publishing: 124] [Article Influence: 11.7] [Reference Citation Analysis]
33 Freudenberg F, Leonard MR, Liu SA, Glickman JN, Carey MC. Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol 2010;299:G205-14. [PMID: 20430874 DOI: 10.1152/ajpgi.00341.2009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
34 Sun H, Warren J, Yip J, Ji Y, Hao S, Han W, Ding Y. Factors Influencing Gallstone Formation: A Review of the Literature. Biomolecules 2022;12:550. [DOI: 10.3390/biom12040550] [Reference Citation Analysis]
35 Davidson NO. Rafting for gallstones by slowing mass transit. J Physiol 2012;590:2067-8. [PMID: 22548910 DOI: 10.1113/jphysiol.2012.231621] [Reference Citation Analysis]
36 Xie Y, Cifarelli V, Pietka T, Newberry EP, Kennedy SM, Khalifeh-Soltani A, Clugston R, Atabai K, Abumrad NA, Davidson NO. Cd36 knockout mice are protected against lithogenic diet-induced gallstones. J Lipid Res 2017;58:1692-701. [PMID: 28634191 DOI: 10.1194/jlr.M077479] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
37 Marschall HU, Einarsson C. Gallstone disease. J Intern Med. 2007;261:529-542. [PMID: 17547709 DOI: 10.1111/j.1365-2796.2007.01783.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 5.6] [Reference Citation Analysis]
38 Xie Y, Fung HY, Newberry EP, Kennedy S, Luo J, Crooke RM, Graham MJ, Davidson NO. Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice. J Lipid Res 2014;55:540-8. [PMID: 24474819 DOI: 10.1194/jlr.M046342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
39 Lammert F, Gurusamy K, Ko CW, Miquel JF, Méndez-Sánchez N, Portincasa P, van Erpecum KJ, van Laarhoven CJ, Wang DQ. Gallstones. Nat Rev Dis Primers 2016;2:16024. [PMID: 27121416 DOI: 10.1038/nrdp.2016.24] [Cited by in Crossref: 160] [Cited by in F6Publishing: 131] [Article Influence: 26.7] [Reference Citation Analysis]
40 Chuang SC, Hsi E, Lee KT. Genetics of gallstone disease. Adv Clin Chem 2013;60:143-85. [PMID: 23724744 DOI: 10.1016/b978-0-12-407681-5.00005-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
41 Richter D, Harsch S, Strohmeyer A, Hirobe-jahn S, Schimmel S, Renner O, Müller O, Schäffeler E, Kratzer W, Schwab M, Stange EF. MALDI-TOF mass spectrometry screening of cholelithiasis risk markers in the gene of HNF1alpha. Journal of Proteomics 2012;75:3386-99. [DOI: 10.1016/j.jprot.2012.04.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
42 Zhang J, Handy DE, Wang Y, Bouchard G, Selhub J, Loscalzo J, Carey MC. Hyperhomocysteinemia from trimethylation of hepatic phosphatidylethanolamine during cholesterol cholelithogenesis in inbred mice. Hepatology 2011;54:697-706. [PMID: 21567442 DOI: 10.1002/hep.24428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
43 Zimmer V, Lammert F. Role of genetics in diagnosis and therapy of acquired liver disease. Molecular Aspects of Medicine 2014;37:15-34. [DOI: 10.1016/j.mam.2013.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
44 Wang DQ, Cohen DE, Carey MC. Biliary lipids and cholesterol gallstone disease. J Lipid Res 2009;50 Suppl:S406-11. [PMID: 19017613 DOI: 10.1194/jlr.R800075-JLR200] [Cited by in Crossref: 114] [Cited by in F6Publishing: 57] [Article Influence: 8.1] [Reference Citation Analysis]
45 Doherty G, Manktelow M, Skelly B, Gillespie P, Bjourson AJ, Watterson S. The Need for Standardizing Diagnosis, Treatment and Clinical Care of Cholecystitis and Biliary Colic in Gallbladder Disease. Medicina 2022;58:388. [DOI: 10.3390/medicina58030388] [Reference Citation Analysis]
46 Li W, Liang J, Shao W, Xu C, Xu J, Jiang Z, Gu A. Maternal smoking during pregnancy is risk factor for gallbladder disease in offspring during adulthood: a prospective study from UK Biobank. Ann Hepatol 2021;:100558. [PMID: 34653688 DOI: 10.1016/j.aohep.2021.100558] [Reference Citation Analysis]
47 Xie Y, Blanc V, Kerr TA, Kennedy S, Luo J, Newberry EP, Davidson NO. Decreased expression of cholesterol 7alpha-hydroxylase and altered bile acid metabolism in Apobec-1-/- mice lead to increased gallstone susceptibility. J Biol Chem 2009;284:16860-71. [PMID: 19386592 DOI: 10.1074/jbc.M109.010173] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
48 Katsika D, Magnusson P, Krawczyk M, Grünhage F, Lichtenstein P, Einarsson C, Lammert F, Marschall HU. Gallstone disease in Swedish twins: risk is associated with ABCG8 D19H genotype. J Intern Med 2010;268:279-85. [PMID: 20497293 DOI: 10.1111/j.1365-2796.2010.02249.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
49 Xie M, Kotecha VR, Andrade JD, Fox JG, Carey MC. Augmented cholesterol absorption and sarcolemmal sterol enrichment slow small intestinal transit in mice, contributing to cholesterol cholelithogenesis. J Physiol 2012;590:1811-24. [PMID: 22331417 DOI: 10.1113/jphysiol.2011.224717] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
50 Wang HH, Portincasa P, Afdhal NH, Wang DQ. Lith Genes and Genetic Analysis of Cholesterol Gallstone Formation. Gastroenterology Clinics of North America 2010;39:185-207. [DOI: 10.1016/j.gtc.2010.02.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
51 Shih SC, Yang HW, Chang TY, Wang HY, Hu KC, Chang CW, Chang CW, Hung CY, Lin M, Chan HW, Lin WS, Chang SC, Lee YJ. Gender-specific association of the interleukin 18 gene with symptomatic gallstone disease. J Gastroenterol Hepatol 2013;28:744-9. [PMID: 23302036 DOI: 10.1111/jgh.12117] [Reference Citation Analysis]